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Abstract
Purpose: Recent doubts regarding the efficacy may have resulted in a loss of interest for targeted temperature
management (TTM) in comatose cardiac arrest (CA) patients, with uncertain consequences on outcome. We aimed
to identify a change in TTM use and to assess the relationship between this change and neurological outcome.
Methods: We used Utstein data prospectively collected in the Sudden Death Expertise Center (SDEC) registry
(capturing CA data from all secondary and tertiary hospitals located in the Great Paris area, France) between May
2011 and December 2017. All cases of non-traumatic OHCA patients with stable return of spontaneous circulation
(ROSC) were included. After adjustment for potential confounders, we assessed the relationship between changes
over time in the use of TTM and neurological recovery at discharge using the Cerebral Performance Categories
(CPC) scale.
Results: Between May 2011 and December 2017, 3925 patients were retained in the analysis, of whom 1847 (47%)
received TTM. The rate of good neurological outcome at discharge (CPC 1 or 2) was higher in TTM patients as
compared with no TTM (33% vs 15%, P < 0.001). Gender, age, and location of CA did not change over the years.
Bystander CPR increased from 55% in 2011 to 73% in 2017 (P < 0.001) and patients with a no-flow time longer than
3 min decreased from 53 to 38% (P < 0.001). The use of TTM decreased from 55% in 2011 to 37% in 2017 (P <
0.001). Meanwhile, the rate of patients with good neurological recovery remained stable (19 to 23%, P = 0.76). After
adjustment, year of CA occurrence was not associated with outcome.
Conclusions: We report a progressive decrease in the use of TTM in post-cardiac arrest patients over the recent
years. During this period, neurological outcome remained stable, despite an increase in bystander-initiated
resuscitation and a decrease in “no flow” duration.
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Introduction
Over the last decades, implementation of the “chain of
survival” led to a progressive improvement in outcome
after cardiac arrest (CA) in many places across the world
[1]. In addition to pre-hospital management, post-
cardiac arrest care is now considered as a major deter-
minant of outcome. Among the interventions that can
be provided during the post-resuscitation period, recent
data raised some concerns regarding the benefit of tar-
geted temperature management (TTM) for comatose
CA survivors. Even if TTM is strongly recommended in
out-of-hospital CA provoked by a ventricular
arrhythmia, its effectiveness has been seriously chal-
lenged in several other situations, such as in non-
shockable [2] and in-hospital CA patients [3]. Addition-
ally, the TTM trial that showed no difference between
33 and 36° may have been falsely considered by some
clinicians as a negative study regarding the effectiveness
of TTM [4]. On the whole, this may have resulted in a
change in TTM modalities in post-cardiac patients, as
reported by several investigators [5]. In a recent survey,
Deye et al. observed that 37% of responders changed
their attitude regarding TTM over the recent years,
many of them moving from 33 °C toward a higher
temperature level [6].
Possible consequences of these changes on patients’
outcome are unclear. After moving from a TTM target
of 33 to 36 °C, Bray et al. reported low compliance with
target temperature, higher rates of fever, and a trend to-
ward clinical worsening in patient outcomes [7]. In a re-
cent retrospective study performed in Australia and New
Zealand, similar changes in clinicians’ attitude regarding
target temperature after CA, which occurred in up to
one third of ICU, were associated with an increased pro-
portion of patients with fever [5]. In the USA, where this
treatment was historically less employed as compared
with European countries, TTM use was shown to further
decrease in many centers, as revealed by recent adminis-
trative data [8]. In parallel, Khera et al. found that TTM
use dropped in all subgroups of CA survivors (both
shockable and non-shockable) [9]. On the whole, these
uncertainties prompted to perform new large random-
ized trials testing this treatment in CA patients. The re-
cently released HYPERION study showed an
improvement in long-term neurological prognosis with
TTM at 33° as compared to normothermia for CA pa-
tients with non-shockable rhythm [10], and the TTM2
trial comparing TTM at 33° versus fever control is actu-
ally ongoing.
We hypothesized that a change in French clinicians’
attitude regarding TTM may have occurred in the
period that preceded these new trials and that this
change may have affected the outcome in post-CA pa-
tients. In order to explore this hypothesis, we decided to
perform an in-depth analysis of a regional registry cover-
ing the Great Paris area (France).
Materials and methods
Study design
We used data extracted from the cardiac arrest registry
managed by the Sudden Death Expertise Center (SDEC)
of the Great Paris area (France), which was previously
described [11]. Our aim was to search for a change in
the use of TTM over the recent years and to assess the
relationship between this change and the patient’s out-
come after adjustment for potential confounders.
Study setting
In Paris and its surrounding suburbs (Haut-de-Seine,
Seine-Saint-Denis, Val-de-Marne), the management of
OHCA involves mobile emergency units and fire depart-
ments, covering 762 km2 and a population of 6.6 million
inhabitants. The Emergency Medical Service is a two-
tiered physician-manned system, with a basic life sup-
port (BLS) tier served by firefighters of the Brigade de
Sapeurs-Pompiers de Paris, who can apply automated
external defibrillators, and an advanced cardiac life sup-
port (ACLS) tier, provided in the field, with endotracheal
intubation, intravenous access line, and drugs if neces-
sary. Resuscitation is delivered by an emergency team
that includes at least one trained physician in emergency
medicine and one nurse, applying international guide-
lines. Patients with stable return of spontaneous circula-
tion (ROSC) are then transferred to a secondary or
tertiary center with an intensive care unit (ICU) and cor-
onary intervention facilities with a target of door to bal-
loon of 120 min maximum for acute coronary syndrome
with ST elevation on ECG.
From 2011, all OHCA cases occurring in Paris and its
suburbs are recorded in a prospective population-based
registry system managed by the Paris Sudden Death Ex-
pertise Center (Paris-SDEC) [12, 13].
Study population
According to recent guidelines [14], all cases of OHCA
(defined as unexpected death without obvious extra-
cardiac cause, such as drowning, trauma, hanging, in-
toxication) are prospectively recorded in the Paris-SDEC
registry according to Utstein style. In the present ana-
lysis, we retained all post-cardiac arrest patients trans-
ported to the hospital and admitted in ICU with a
sustainable ROSC from May 15, 2011, to December 31,
2017. Exclusion criteria were age below 18 years, prior
terminal condition (e.g., metastatic malignancy), obvious
non-cardiac cause according to Utstein templates [14],
patients who died before hospital admission, and refrac-
tory OHCA transported to the hospital for potential
extra-corporal life support (ECLS).
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Data collection
The following variables are collected in the registry: age,
gender, location, witnessed status, bystander cardiopul-
monary resuscitation, initial cardiac rhythm, cumulative
epinephrine dose employed during resuscitation, delays
from collapse to start of chest compressions (no flow)
and from start of chest compression to ROSC (low flow),
characteristics of the post-resuscitation ECG, arterial pH
at hospital admission, temperature management, and
coronary interventions after hospital admission.
The neurological outcome was scored using the level
reached on the Cerebral Performance Categories (CPC)
scale [15] at ICU discharge, assessed by the physician in
charge. Patients with a good cerebral performance
(CPC1) or a moderate cerebral disability (CPC2) were
considered to have a favorable neurological recovery.
Patients’ management
TTM was considered as the provision of any measure
aiming to reduce the patient’s body temperature by ei-
ther non-invasive or by invasive means. According to
current guidelines, the targeted temperature was com-
prised between 32 and 36 °C [16]. TTM could be started
in the emergency department or in the ICU according to
each center policy.
Early invasive coronary strategy was defined as a cor-
onary angiography (followed by percutaneous coronary
intervention if indicated) performed in the very first
hours following hospital admission. Post-resuscitation
shock was defined as the occurrence or persistence of
arterial hypotension (mean arterial pressure < 60 mmHg
or systolic blood pressure < 90mmHg) sustained for
more than 6 h after ROSC despite adequate fluid resusci-
tation and requiring a continuous infusion of
vasopressor.
Definitions and modalities for data collection were un-
changed during the period of the study. Data were en-
tered prospectively into a study database and checked
for completeness and accuracy. Two investigators (FD,
AC) reviewed each record for data completion and
validity.
Statistical analysis
We used descriptive statistics to summarize categorical
variables as proportions, and continuous variables as
mean with standard deviation for normal distribution or
as median with interquartile range for non-normal dis-
tribution. Comparisons between proportions used Pear-
son’s chi-squared (or Fisher’s exact test if appropriate)
and t test for continuous variables (or Mann-Wilcoxon
rank-sum test).
According to the different analyses, we used three dif-
ferent options regarding the “year of cardiac arrest,”
which was analyzed as a continuous or a categorical
variable, or divided into four a priori defined periods (P)
based on the publication of the TTM trial [3]: P1 was
the baseline period (year 2011); P2 was the period before
the publication of the TTM trial (years 2012 and 2013);
P3 was the period that immediately followed the publi-
cation of the TTM trial (year 2014), and P4 being the
most recent period (years 2015, 2016, and 2017).
We first assessed the relationship between baseline
characteristics and the use of TTM. Test for trend and
logistic regression were used to evaluate the pattern of
neurological recovery over time and the potential ex-
plicative factors.
We then performed a univariate analysis testing the
different parameters associated with good neurological
recovery at ICU discharge. Association between TTM
and outcome was analyzed in a multivariate model ad-
justed on Utstein variables including age, gender, loca-
tion of arrest, provision of bystander CPR, resuscitation
intervals, initial rhythm, epinephrine use, arterial pH at
admission, occurrence of a post-cardiac arrest shock,
early coronary angiogram performance, TTM, and year
of arrest as continuous. In order to take into account
missing data, we performed multiple imputations using
chained equation [17] on the dataset restricted to pa-
tients with available survival status at hospital discharge
(primary outcome), based on M = 10 imputed completed
datasets.
In a sensitivity analysis aiming to assess the influence
of prognostic factors over time, we included in the pri-
mary multivariate model an interaction (cross-product)
term between year and covariates of interest (initial
rhythm, bystander CPR performance, TTM).
Focusing on the role of TTM, we also evaluated the
potential for generalized temporal trends to account for
the study period association by using segmented regres-
sion analysis of interrupted time series data using time
categorized in four a priori sub-periods (P1, P2, P3, and
P4). This method allows to assess how much an inter-
vention changed an outcome of interest, immediately
and over time [18].
All tests were two-sided with a P value considered sig-
nificant if < 0.05. Analyses were performed using STAT
A/SE 14.2 (Lakeway Drive, TX, USA).
Results
During the study period, 25,059 patients were included
in the Paris-SDEC registry. Cardiopulmonary resuscita-
tion was not attempted in 7923 patients, an obvious
non-cardiac cause of arrest was evidenced in 3782 pa-
tients, resuscitation failed in 8766 patients (who were
not transported according to French EMS policy), and
663 patients with refractory CA were transported with-
out ROSC to the hospital for potential extra-corporeal
life support. This left 3925/25059 (16%) patients suitable
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for the present analysis, of whom 1847/3925 (47%) re-
ceived TTM (see Additional file 1). Numbers of missing
data are displayed on Additional file 2.
Patients’ characteristics according to temperature
management are displayed in Table 1. As compared with
controls, those who received TTM were more frequently
men and younger; cardiac arrest occurred more fre-
quently in a public place, and the proportion of patients
with a long no-flow duration (higher than 3min) was
greater (P < 0.001). An early invasive coronary strategy
was used more frequently in TTM patients (P < 0.001).
As compared with controls, those who received TTM
had more frequently a good neurological recovery at
ICU discharge (15% vs 33%, P < 0.001).
Changes over the years in patients’ characteristics and
management appear in Table 2. Gender, age, and loca-
tion of CA did not significantly change over time. By-
stander CPR increased from 55% in 2011 to 73% of
patients in 2017 (P < 0.001), no-flow time upper than 3
min decreased from 53 to 38% (P < 0.001) (Table 2).
During the study period, the overall proportion of pa-
tients receiving TTM decreased from 55% in 2011 to
37% in 2017 (P < 0.001). This decrease in TTM use over
years was observed in both shockable and non-shockable
patients (see Fig. 1). Using segmented regression separ-
ating the study period into four separate sub-periods
(P1 = 2011, P2 = 2012–2013, P3 = 2014, P4 = 2015–17),
the decrease in TTM use was significant for P3 vs. P2
(OR = 0.78 [0.64–0.96] P = 0.02) and P4 vs. P3 (OR =
0.77 [0.63–0.94] P = 0.009). In parallel, the survival rate
at ICU discharge increased significantly from 20% in
2011 to 26% in 2017 (P = 0.03), but the proportion of
patients with good neurological outcome remained
stable (19 to 23%; P = 0.76) (Fig. 3).
In univariate analysis, TTM was significantly associ-
ated with a better neurological outcome with OR = 2.71
[2.30–3.19] and was associated with a better outcome
after adjustment on baseline characteristics and year of
arrest (adjOR = 1.57 [1.22–2.02]). Considering 2011 as
the year of reference, a later onset of CA was not associ-
ated with a better outcome in univariate analysis (P =
0.75) (Table 3). In addition, no interaction term between
year of occurrence and parameters of interest (initial
rhythm, bystander CPR performance, TTM) was signifi-
cant (P for interaction > 0.10).
Using segmented regression separating the study
period into four separate sub-periods, the association be-
tween neurological outcome and periods was significant
only for P4 vs. P3 (OR = 0.77 [0.62–0.95]; P = 0.015) (see
Figs. 2 and 3).
Discussion
Using the Paris-SDEC registry, which covers a large geo-
graphic area in France, we report that the overall pro-
portion of post-cardiac arrest patients who received
TTM decreased over years between 2011 and 2017. This
decrease was observed in all patients’ subgroups. In par-
allel, we observed that the activation of early resuscita-
tion improved over time as reflected by an increase in
the proportion of patients who received bystander CPR
and a decrease in the proportion of patients with a long
“no flow.” Despite these improvements in early manage-
ment, there was no significant change in neurological
outcome over the study period.
Table 1 Characteristics of the study population according to targeted temperature management
No TTM (n = 1793) TTM (n = 1847) P
Male, n % 1169 (65%) 1318 (71%) < 0.001
Age, ±SD 64 ± 16 61 ± 15 < 0.001
Home location, n % 1186 (66%) 1017 (55%) < 0.001
Witness, n % 1569 (87%) 1697 (92%) < 0.001
Bystander CPR, n % 1142 (63%) 1195 (65%) < 0.001
Shockable rhythm, n % 592 (33%) 1065 (58%) < 0.001
No-flow duration > 3min*, n % 666 (37%) 881 (48%) < 0.001
Low-flow duration > 20 min*, n % 588 (33%) 760 (42%) < 0.001
Epinephrine use, n % 1259 (70%) 1224 (66%) < 0.001
First arterial pH, ±SD 7.13 ± 0.22 7.22 ± 0.15 < 0.001
Post-resuscitation shock, n % 863 (48%) 1253 (68%) < 0.001
Early invasive coronary strategy, n % 767 (43%) 1494 (80%) < 0.001
Survival at ICU discharge, n % 370 (20%) 689 (37%) < 0.001
Good neurological prognosis at ICU discharge, n % 273 (15%) 618 (33%) < 0.001
Values are expressed with proportion (%), mean with standard deviation (SD)
CPR cardiopulmonary resuscitation
*Characteristics were dichotomized according to the median value
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Recent doubts regarding the efficacy of targeted
temperature management (TTM) may have resulted in a
loss of interest for this treatment in comatose cardiac ar-
rest (CA) patients. Indeed, following the publication of
the TTM trial in 2013, several observational studies re-
ported a change in ICU policies regarding temperature
management after cardiac arrest. Up to one third of
intensivists changed their temperature target from 33 to
36 °C [6]. Using data from France (where therapeutic
hypothermia is commonly used [19]), we report a clear
fall in the use of TTM that was not associated with a
change in neurological outcome over the same period.
In a first approach, these findings do not suggest a detri-
mental effect of a lesser use of TTM on outcome in this
population. However, this could have been concealed by
a parallel improvement in the chain of survival that may
have masked a negative effect of the decrease in the use
of TTM. This interpretation is supported by the
Table 2 Baseline characteristics evolution over the years
All 2011 2012 2013 2014 2015 2016 2017 P for trend
N 3925 339 562 589 594 559 620 662
Male, n (%) 2682 (70%) 235 (70%) 386 (68%) 395 (67%) 401 (67%) 394 (70%) 442 (71%) 429 (65%) 0.63
Age, mean ± SD 62 ± 15 62 ± 14 62 ± 15 62 ± 15 62 ± 16 61 ± 15 63 ± 15 62 ± 16 0.17
Home location, n (%) 2365 (58%) 206 (60%) 341 (60%) 338 (57%) 342 (57%) 338 (60%) 392 (63%) 408 (61%) 0.17
Witnessed, n (%) 3504 (90%) 320 (94%) 502 (89%) 516 (88%) 534 (90%) 489 (87%) 543 (88%) 600 (90%) 0.44
Bystander CPR, n (%) 2525 (66%) 186 (55%) 310 (55%) 359 (60%) 384 (65%) 365 (65%) 437 (70%) 484 (73%) < 0.001
Initial shockable rhythm, n (%) 2215 (50%) 130 (38%) 256 (45%) 273 (46%) 298 (50%) 251 (45%) 289 (46%) 287 (43%) 0.26
No flow > 3 min*, n (%) 1784 (40%) 179 (53%) 231 (41%) 236 (40%) 248 (42%) 232 (41%) 234 (38%) 253 (38%) < 0.001
Low flow > 20 min*, n (%) 1613 (39%) 121 (36%) 203 (36%) 207 (35%) 185 (31%) 198 (35%) 219 (35%) 264 (40%) 0.039
Use of epinephrine, n (%) 2646 (70%) 245 (72%) 373 (66%) 401 (68%) 401 (67%) 393 (70%) 396 (64%) 437 (66%) 0.10
First arterial pH, mean ± SD 7.2 ± 0.2 7.2 ± 0.2 7.2 ± 0.2 7.2 ± 0.2 7.2 ± 0.2 7.2 ± 0.2 7.2 ± 0.2 7.2 ± 0.2 0.49
Post-resuscitation shock, n (%) 2149 (56%) 253 (74%) 388 (69%) 338 (57%) 270 (45%) 305 (54%) 318 (51%) 277 (42%) < 0.001
Early invasive coronary strategy, n (%) 2349 (60%) 202 (60%) 336 (60%) 354 (60%) 367 (62%) 335 (60%) 388 (63%) 367 (55%) 0.13
Targeted temperature management, n (%) 1847 (47%) 189 (55%) 321 (57%) 311 (53%) 275 (46%) 230 (41%) 278 (45%) 243 (37%) < 0.001
Survival at ICU discharge, n (%) 1106 (26%) 70 (20%) 153 (27%) 181 (30%) 188 (32%) 161 (29%) 176 (28%) 177 (26%) 0.03
Good neurological prognosis at ICU discharge, n (%) 921 (23%) 63 (19%) 141 (26%) 160 (28%) 151 (27%) 135 (26%) 147 (26%) 124 (23%) 0.76
Values are expressed with proportion (%), mean with standard deviation (SD)
CPR cardiopulmonary resuscitation
*Characteristics were dichotomized according to the median value
Fig. 1 Changes in TTM use over time according to initial cardiac rhythm
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Table 3 Factors associated with good neurological prognosis at ICU discharge in uni- and multivariate analysis in multiple
imputation cohort (N = 3623 patients)
Characteristics Univariate analysis Multivariate analysis
Coefficient [95%CI] P value Coefficient [95%CI] P value
Male 1.65 [1.39–1.97] < 0.001 – –
Age 0.97 [0.96–0.98] < 0.001 0.96 [0.95–0.97] < 0.001
Home location 0.32 [0.27–0.38] < 0.001 0.59 [0.47–0.74] < 0.001
Bystander CPR 2.62 [2.16–3.19] < 0.001 1.65 [1.19–2.28] 0.003
Shockable rhythm 9.70 [8.04–11.70] < 0.001 2.96 [2.29–3.93] < 0.001
No flow > 3min* 0.38 [0.32–0.45] < 0.001 0.48 [0.36–0.64] < 0.001
Low flow > 20min* 0.21 [0.17–0.26] < 0.001 0.50 [0.38–0.66] < 0.001
Epinephrine use* 0.06 [0.05–0.08] < 0.001 0.15 [0.11–0.19] < 0.001
First arterial pH (by 0.1 unit) 1.86 [1.73–2.00] < 0.001 1.31 [1.20–1.45] < 0.001
Post-resuscitation shock 0.44 [0.37–0.42] < 0.001 0.73 [0.57–0.94] 0.012
Early invasive coronary strategy 8.16 [6.50–10.25] < 0.001 3.24 [2.37–4.43] < 0.001
Targeted temperature management 2.71 [2.30–3.19] < 0.001 1.57 [1.22–2.02] < 0.001
Year of occurrence (2011 as reference) 1.01 [0.96–1.05] 0.75 – –
CPR cardiopulmonary resuscitation
*Characteristics were dichotomized according to the median value
Fig. 2 Changes in characteristics and outcome according to periods of segmented regression analysis
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protective effect of TTM that was observed in multivari-
able analysis and also by the segmented regression,
which reveals a change in the association between
neurological outcome and periods for the most recent
years. On the whole, it is not possible to exclude that an
improvement in outcome may have been observed if
TTM had been more widely used. Of course, the design
of the present study does not allow giving any firm con-
clusion regarding this debate.
The existence of an association between changes in
TTM policies and outcome is debated as previous au-
thors reported conflicting results [20, 21]. Our results
are in accordance with those from a recent North-
American study [8], which explored a quite similar
population of post-cardiac arrest patients. On the oppos-
ite, our results are discordant with those from Salter
et al. [5], who reported an association between the pro-
gressive switch from 33 to 36 °C and an increase in both
the proportion with fever in ICU and hospital mortality.
However, there was no adjustment for major Utstein
style confounders in the analysis. In the present study,
we observed an increase over the years in bystander CPR
and a decrease in no-flow duration, which are both
major determinants of outcome [5]. We strongly believe
that any further studies aiming to assess the relationship
between post-cardiac arrest care and outcome should be
adjusted on these major variables.
The loss of confidence in TTM may have been sus-
pected to be deeper in non-shockable patients since the
level of evidence regarding its efficacy was lower in this
population, as compared with shockable patients [2].
However, a clear insight from the present study is that
the lower adherence to TTM after CA was not driven by
the cardiac rhythm at EMS presentation, since the de-
crease was observed in both shockable and non-
shockable patients. In several retrospective studies, bene-
fits from TTM at 33 °C were more marked in patients
with longer no-flow or low-flow times [22–24], but this
result was not replicated in a post hoc analysis of the
TTM trial [25]. In this context, it is unfortunate to ob-
serve that the fall in TTM use is also observed in shock-
able patients despite a strong recommendation in recent
guidelines [16]. Regarding the subgroup of non-
shockable patients, TTM use might increase in the next
future due to the results of the HYPERION trial, which
showed a significant improvement in neurological out-
come at day 90 with TTM at 33° as compared with nor-
mothermia [10].
The results of the present study suggest that the
TTM trial may have been inaccurately interpreted as
a negative study and may have discouraged the use
of therapeutic hypothermia in post-cardiac patients.
Even if the TTM trial was not designed to assess the
efficacy of therapeutic hypothermia, the lack of dif-
ference in neurological outcome between patients
managed at 33° versus 36° was probably considered
as a negative signal regarding the efficacy of cooling.
In the meantime, pivotal studies that established the
efficacy of TH in post-cardiac arrest patients were
challenged in several aspects (low number of
Fig. 3 Changes in neurological outcome according to periods of segmented regression analysis
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patients, highly selected population, temperature
strategy in the control group) [26, 27]. Since cooling
is a time-consuming treatment, this may explain the
disaffection for this treatment. In this way, a particu-
lar attention should be paid to the results of the
TTM-2 study, which is a large multicentric prag-
matic trial comparing moderate hypothermia and
normothermia in comatose cardiac patients [28].
Our results should be considered in the context of the
study’s limitations. We were unable to comment on po-
tential changes in the quality of therapeutic hypothermia
(e.g., time to target temperature and time in target
temperature) that may also impact patients’ outcome
[29]. The higher proportion of patients with a short no-
flow duration is in sharp contrast to prior studies [30],
but this proportion is close to what was reported in a
non-selected north-American registry [31]. In addition,
we decided to study the specific population of patients
with a stable ROSC after hospital and ICU admission, a
population in which the proportion of shockable patients
is known to be high [32]. We were not able to identify
the subset of patients who were managed with a strategy
of “normothermia or avoiding fever” among those who
did not receive TTM. However, each patient’s chart was
evaluated by a centralized monitor who checked the
medical file for accuracy and competitiveness. Patients
in the TTM group were younger, and even after multi-
variate adjustment, other unmeasured confounders may
potentially explain their better outcome. Finally, only
short-term outcome was considered, while long-term
outcome would have been more adapted (such as 1-
month and 3-month outcome as recommended in
COSCA guidelines [33]) and we cannot exclude than
some non-survivors died of non-neurological cause [34].
Conclusion
Using a large regional registry of cardiac arrest, we re-
port a progressive decrease in the use of TTM in post-
cardiac arrest patients over the recent years. In parallel,
we observed that the activation of early resuscitation im-
proved over time as reflected by an increase in the pro-
portion of patients who received bystander-initiated
resuscitation and a shorter “no flow.” Despite these im-
provements in early management, there was no signifi-
cant change in neurological outcome over the study
period. Further research is required to explore the con-
sequence of this decrease in the use of TTM.
Supplementary information
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1186/s13054-019-2677-1.
Additional file 1. Patient flowchart.
Additional file 2. Proportion of missing values in the study population.
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Take-home message
Use of targeted temperature management after cardiac arrest declined over
the years in both shockable and non-shockable patients. After adjustment
for major confounders, this decline was not associated with a change in
neurological outcome at ICU discharge.
Tweet
Use of #TTM after #OHCA declined over the years in both shockable and
non-shockable patients. After adjustment, this decline was not associated
with a change in neurological outcome at ICU discharge.
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